A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study
- PMID: 12819906
- DOI: 10.1007/s00125-003-1141-5
A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study
Abstract
Aims/hypothesis: Type 2 diabetes is not only associated with hyperglycaemia, but also with disorders of lipid metabolism. The aim of this study was to investigate the association of triglyceride and non-HDL-cholesterol concentrations with cardiovascular disease in subjects with normal and abnormal glucose metabolism.
Methods: Subjects were 869 men and 948 women aged 50 to 75 who participated in the Hoorn Study, a population-based cohort study that started in 1989. Glucose metabolism was determined by a 75 g OGTT. High fasting triglyceride and non-HDL-cholesterol concentrations were defined as above the median of the study population.
Results: After 10 years of follow-up, the age- and sex-adjusted hazard ratios for cardiovascular disease were 1.35 (1.11-1.64) and 1.71 (1.40-2.08) for high triglycerides and high non-HDL-cholesterol, respectively, after mutual adjustment. After stratification for glucose metabolism status, the hazard ratios for cardiovascular disease for non-HDL-cholesterol were 1.70 (1.31-2.21) in normal glucose metabolism and 1.56 (1.12-2.18) in abnormal glucose metabolism. Triglycerides were not a risk factor in subjects with normal glucose metabolism, with a hazard ratio of 0.94 (0.73-1.22), but in subjects with abnormal glucose metabolism, the hazard ratio for cardiovascular disease was 1.54 (1.07-2.22). In subjects with abnormal glucose metabolism, the hazard ratio for the combined presence of high triglycerides and non-HDL-cholesterol was 2.12 (1.35-3.34).
Conclusion: Our data suggest that in people with abnormal glucose metabolism, but not in those with normal glucose metabolism, high triglyceride concentration could be associated with the risk of cardiovascular disease, particularly in people with high non-HDL-cholesterol.
Similar articles
-
Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.Appl Physiol Nutr Metab. 2009 Apr;34(2):136-42. doi: 10.1139/H08-149. Appl Physiol Nutr Metab. 2009. PMID: 19370043
-
The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk.J Clin Endocrinol Metab. 2010 Sep;95(9):4345-53. doi: 10.1210/jc.2010-0361. Epub 2010 Jul 14. J Clin Endocrinol Metab. 2010. PMID: 20631030
-
Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation.Diabetes Care. 2001 May;24(5):902-8. doi: 10.2337/diacare.24.5.902. Diabetes Care. 2001. PMID: 11347752
-
Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):150-6. doi: 10.1097/MED.0000000000000241. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 26863278 Review.
-
Impaired glucose tolerance. Why is it not a disease?Diabetes Care. 1999 Jun;22(6):883-5. doi: 10.2337/diacare.22.6.883. Diabetes Care. 1999. PMID: 10372235 Review. No abstract available.
Cited by
-
Association between Triglycerides to High-Density Lipoprotein Cholesterol Ratio and Death Risk in Diabetic Patients with New-Onset Acute Coronary Syndrome: A Retrospective Cohort Study in the Han Chinese Population.Rev Cardiovasc Med. 2022 May 26;23(6):190. doi: 10.31083/j.rcm2306190. eCollection 2022 Jun. Rev Cardiovasc Med. 2022. PMID: 39077180 Free PMC article.
-
Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.Postgrad Med J. 2005 Jan;81(951):1-6. doi: 10.1136/pgmj.2004.020511. Postgrad Med J. 2005. PMID: 15640422 Free PMC article. Review.
-
Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.Vasc Health Risk Manag. 2008;4(1):143-56. doi: 10.2147/vhrm.2008.04.01.143. Vasc Health Risk Manag. 2008. PMID: 18629364 Free PMC article. Review.
-
Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.Lipids Health Dis. 2014 Apr 27;13:73. doi: 10.1186/1476-511X-13-73. Lipids Health Dis. 2014. PMID: 24766776 Free PMC article.
-
Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.Diabetologia. 2005 Jun;48(6):1207-15. doi: 10.1007/s00125-005-1753-z. Epub 2005 Apr 30. Diabetologia. 2005. PMID: 15864534
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical